Press Release: The Journal of Managed Care & Specialty Pharmacy (JMCP) is pleased to announce the addition of two experienced managed care pharmacy experts to the JMCP editorial team.
December 2018 News & Views: Partnership Forum Examines Role of IDNs in Value-Based Agreements; JMCP Adds Two Editors in Response to Growing Article Submissions; AMCP Annual Meeting Registration Is Open
Leg-Reg Briefing December 2018: Advocacy on Many Fronts; 2019 State Advocacy Coordinators; Proposed Rule on Part D and Medicare Advantage; Regulations on Drug Pricing Transparency
On November 26, The Centers for Medicare and Medicaid Services (CMS) issued a new proposed rule outlining potential policies that are intended to lower the cost of prescription drugs through tools that allow prescription drug plans to negotiate prices and by improving access to costly drugs through reduction of out-of-pocket costs for beneficiaries.
On November 26, 2018, CMS issued a new proposed rule outlining potential policies that are intended to lower the cost of prescription drugs. Major Provisions in the proposed rule include; Providing Part D Prescription Drug Plan (PDP) flexibility to negotiate discounts for drugs in protected classes; Utilizing Real Time Benefits Tools (RTBT) in the Part D Program to increase drug price transparency at the point of prescribing; Codifying a policy to allow step therapy in Medicare Advantage for Part B Drugs; Amending regulations related to the Part D Explanation of Benefits (EOB) that plans send to beneficiaries to include drug pricing information and lower cost alternatives; Implementing a statutory provision prohibiting the use of gag clauses in pharmacy contracts; Considering a policy that would re-define negotiated price as the baseline, or lowest possible, payment to a pharmacy in future plan years as early as 2020.
Press Release: Health care stakeholders aiming to advance the concept of value-based care models should start with small, simple initiatives to help ease compliance and legal concerns, suggested attendees of a recent Academy of Managed Care Pharmacy (AMCP) Partnership Forum
Partnership Forum: Implementing value-based reimbursement models for both pharmaceuticals and medical care poses significant challenges and opportunities, and depends on integrated delivery networks (IDNs) to execute the processes and programs. Industry thought leaders convened to discuss the issues.